Paid Clinical Trials Orange County
Discover 3,276 paid clinical trials in Orange County, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Observational StudyAmyloid Prediction in Early Stage Alzheimer's Disease Through Speech Phenotyping - PAST Extension
Sponsor:
Novoic Limited
Location:
Code:
NCT04937959
Conditions
Alzheimer Disease
Alzheimer's Disease (Incl Subtypes)
Preclinical Alzheimer's Disease
Prodromal Alzheimer's Disease
Mild Cognitive Impairment
Eligibility Criteria
Sex: All
Age: 50 - 70+
Healthy Volunteers: Accepted
FarudodstatInvestigate the Efficacy and Safety of Farudodstat Compared With Its Placebo in Adult Alopecia Areata Participants
Sponsor:
ASLAN Pharmaceuticals
Location:
Code:
NCT05865041
Conditions
Alopecia Areata
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Farudodstat
Placebo
MiricorilantA Phase 2b, Study Evaluating Miricorilant in Adult Patients With Nonalcoholic Steatohepatitis/Metabolic Dysfunction-Associated Steatohepatitis (MONARCH)
Sponsor:
Corcept Therapeutics
Location:
Code:
NCT06108219
Conditions
Nonalcoholic Steatohepatitis (NASH)
Metabolic Dysfunction-associated Steatohepatitis (MASH)
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Not accepted
Interventions
Miricorilant (Cohort A)
Placebo (Cohort A)
Miricorilant (Cohort B)
Placebo (Cohort B)
Salivary miRNAValidation of a Salivary miRNA Diagnostic Test for ASD
Sponsor:
Quadrant Biosciences Inc.
Location:
Code:
NCT05418023
Conditions
Autism Spectrum Disorder
Developmental Delay
Eligibility Criteria
Sex: All
Age: 18 - 7
Healthy Volunteers: Not accepted
Interventions
Salivary Collection
Adaptive Assessment
Medical and Demographic questionnaire
Autism Assessment
Intellectual Development Assessment
Observational StudyEmpowering Hispanic Patients' Lung Cancer Screening Uptake (Empower Latinx)
Sponsor:
UCLA
Location:
Code:
NCT06225414
Conditions
Lung Cancer
Eligibility Criteria
Sex: All
Age: 50 - 70+
Healthy Volunteers: Accepted
Interventions
Usual Care
Brief Patient Education
Patient education
Referral to financial navigation resources
Patient Reminders
Interested in new trials?
Get alerts for new trials in your area by subscribing now
CGB-500 with TofacitinibPhase 2b Safety and Efficacy Study of CGB-500 Topical Ointment with 0.5% and 1% Tofacitnib for Treatment of Atopic Dermatitis
Sponsor:
CAGE Bio Inc.
Location:
Code:
NCT06810050
Conditions
Atopic Dermatitis (AD)
Eligibility Criteria
Sex: All
Age: 12+
Healthy Volunteers: Not accepted
Interventions
CGB-500 with 0.5% tofacitinib
CGB-500 Ointment with 1% tofacitinib
Vehicle (placebo)
Disitamab Vedotin vs ChemotherapyDisitamab Vedotin With Pembrolizumab vs Chemotherapy in Previously Untreated Urothelial Cancer Expressing HER2
Sponsor:
Seagen Inc.
Location:
Code:
NCT05911295
Conditions
Urothelial Carcinoma
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
disitamab vedotin
pembrolizumab
gemcitabine
cisplatin
carboplatin
MindfulnessConscious Pregnancy: Supporting Maternal Cardiometabolic Health With Mindfulness
Sponsor:
UCLA
Location:
Code:
NCT06898658
Conditions
Maternal Cardiometabolic Health
Molecular Impact of Psychological Stress and Socioeconomic Adversity
Maternal Inflammatory Markers
Maternal Diabetes
Maternal Behavior
Eligibility Criteria
Sex: Female
Age: 18+
Healthy Volunteers: Accepted
Interventions
Mindfulness Intervention
HBI-2438A Dose Escalation Study of HBI-2438 in Patients With Solid Tumors Harboring KRAS G12C Mutation
Sponsor:
HUYABIO International, LLC.
Location:
Code:
NCT05485974
Conditions
Lung Cancer
Non Small Cell Lung Cancer
Colorectal Cancer
Cancer of Pancreas
Colon Cancer
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
HBI-2438
ElamipretideReNEW:Phase 3 Study of Efficacy, Safety & Pharmacokinetics of Subcutaneous Injections of Elamipretide in Subjects With Dry Age-Related Macular Degeneration (Dry AMD)
Sponsor:
Stealth BioTherapeutics Inc.
Location:
Code:
NCT06373731
Conditions
Age Related Macular Degeneration (ARMD)
Eligibility Criteria
Sex: All
Age: 55+
Healthy Volunteers: Not accepted
Interventions
Elamipretide
Placebo